Corcept Therapeutics (LTS:0I3Q) 3-Year EBITDA Growth Rate : -2.20% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Corcept Therapeutics 3-Year EBITDA Growth Rate?

Corcept Therapeutics's EBITDA per Share for the three months ended in Mar. 2024 was $0.27.

During the past 12 months, Corcept Therapeutics's average EBITDA Per Share Growth Rate was 24.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -2.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Corcept Therapeutics was 119.30% per year. The lowest was -3.00% per year. And the median was 12.80% per year.

Competitive Comparison of Corcept Therapeutics's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Corcept Therapeutics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corcept Therapeutics's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corcept Therapeutics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Corcept Therapeutics's 3-Year EBITDA Growth Rate falls into.

Corcept Therapeutics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Corcept Therapeutics (LTS:0I3Q) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Corcept Therapeutics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Corcept Therapeutics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Corcept Therapeutics (LTS:0I3Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (LTS:0I3Q) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CORT:USA HTD:Germany

Address

149 Commonwealth Drive, Menlo Park, CA, USA, 94025

Website

https://www.corcept.com

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Corcept Therapeutics (LTS:0I3Q) Headlines

No Headlines